A molecular design approach to peptide drug stabilization

被引:1
|
作者
Thompson, S. M.
Sinha, S.
Topp, E. M.
Camarda, K. V. [1 ]
机构
[1] Univ Kansas, Dept Chem & Petr Engn, Lawrence, KS 66045 USA
[2] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA
关键词
molecular simulation; optimization; peptide drugs; polymer;
D O I
10.1080/08927020600612213
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Many peptide drugs are susceptible to chemical degradation. It has been demonstrated experimentally that complexing a polymer to a peptide can prevent its degradation; however, the mechanism behind the stabilizing effect is not known, making it-difficult to design polymers specifically for this purpose. In this work, we have used molecular dynamics experiments to gain insight into the polymer's stabilizing effect. The system AcVYGNGA, a model peptide, which has been extensively studied experimentally, was explored both alone in various forms and complexed with poly(vinylpyrrolidone) (PVP). Results suggest that the peptide-polymer complex must have a secondary structure such that the polymer affects the critical degradation mechanism in two ways: a steric effect based on the polymer's size, and a structural effect by which the physical distance between the reacting atoms within the peptide is increased. These results will be used to develop a set of structure-property relations which can be included within an optimization framework to design new polymers for peptide stabilization.
引用
收藏
页码:291 / 295
页数:5
相关论文
共 50 条
  • [41] MOLECULAR MODELING, MOLECULAR MECHANICS, AND DRUG DESIGN
    RIPKA, WC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 199 : 154 - ORGN
  • [42] Utilizing genomics and proteomics for peptide based drug design - Drug design for disease reconsidered
    Hruby, Victor J.
    Agnes, Richard
    Vagner, Josef
    Lee, Yeon Sun
    Handl, Heather
    Ma, S. -W
    Davis, Peg
    Herman, David S.
    Vanderah, Todd W.
    Yamamura, Henry I.
    Lai, Josephine
    Gillies, Robert J.
    Porreca, Frank
    Peptides 2004, Proceedings: BRIDGES BETWEEN DISCIPLINES, 2005, : 77 - 80
  • [43] Peptide and peptidomimetic librariesMolecular diversity and drug design
    Fahad Al-Obeidi
    Victor J. Hruby
    Tomi K. Sawyer
    Molecular Biotechnology, 1998, 9 : 205 - 223
  • [44] Peptide-based drug design - Preface
    Gozes, I
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (06)
  • [45] The signal peptide as a new target for drug design
    Lumangtad, Liezel A.
    Bell, Thomas W.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (10)
  • [46] Drug design at peptide receptorsSomatostatin receptor ligands
    Jason P. Hannon
    Caroline Nunn
    Barbara Stolz
    Christian Bruns
    Gisbert Weckbecker
    Ian Lewis
    Thomas Troxler
    Konstanze Hurth
    Daniel Hoyer
    Journal of Molecular Neuroscience, 2002, 18 : 15 - 27
  • [47] Carrier particle design for stabilization and isolation of drug nanoparticles
    Tierney, Teresa
    Bodnar, Katalin
    Rasmuson, Ake
    Hudson, Sarah
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 518 (1-2) : 111 - 118
  • [48] AN ALTERNATIVE APPROACH TO THE DESIGN OF WASTE STABILIZATION PONDS
    JAMES, A
    WATER SCIENCE AND TECHNOLOGY, 1987, 19 (12) : 213 - 218
  • [49] Inhibition of peptide processing and degradation:: a new approach to peptide drug therapy
    Roques, BP
    Llorens-Cortes, C
    Fournié-Zaluski, MC
    BRAIN RESEARCH, 1999, 848 (1-2) : A17 - A17
  • [50] Inhibition of peptide processing and degradation: A new approach to peptide drug therapy
    Noble, F
    Roques, BP
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 163S - 163S